PPARG and type 2 diabetes mellitus: Moreover, studies published in 2012 and 2015 both demonstrated that exercise-triggered monocyte PPARgamma activation might be the mechanism of the benefit created by exercise for patients with type 2 diabetes or related cardiovascular complications [53,54].